Involvement of Endothelin 1 in Remote Preconditioning-Induced Cardioprotection through connexin 43 and Akt/GSK-3β Signaling Pathway

Scientific Reports
Min ZhangXing Yu Hong

Abstract

The present study was aimed to explore the role of endothelins in remote preconditioning (RP)-induced myocardial protection in ischemia-reperfusion (IR) injury. RP stimulus was given by subjecting hind limb to four cycles of ischemia and reperfuion (5 minutes each) using blood pressure cuff in male rats. Following RP, hearts were isolated and subjected to 30 minutes of ischemia and 120 minutes of reperfusion on Langendorff apparatus. The extent of myocardial injury was determined by measuring the levels of LDH-1, CK-MB and cardiac troponin T (cTnT) in coronary effluent; caspase-3 activity and Bcl 2 expression in heart (apoptosis); infarct size by triphenyl tetrazolium chloride and contractility parameters including left ventricular developed pressure, dp/dtmax dp/dtmin and heart rate. RP reduced ischemia reperfusion-induced myocardial injury, increased the levels of endothelin 1 (in blood), Akt-P, GSK-3β-P and P-connexin 43 (in hearts). Pretreatment with ETA receptor antagonist, BQ 123 (1 and 2 mg/kg), ETB receptor antagonist, BQ 788 (1 and 3 mg/kg) and dual inhibitor of ETA and ETB receptor, bonsentan (25 and 50 mg/kg) abolished these effects of RP. However, the effects of bonsentan were more pronounced in comparison to BQ 123...Continue Reading

References

Jan 1, 1993·Cardiology·S QiuB C Solymoss
Sep 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·D R MeldrumA H Harken
Mar 1, 1997·Cardiovascular Research·J Pernow, Q D Wang
Dec 4, 2002·Circulation·R K KharbandaR MacAllister
Jun 25, 2003·Circulation·David A LiemDirk J Duncker
Apr 21, 2004·British Journal of Anaesthesia·M KempJ Hooper
Jun 4, 2008·Cardiovascular Research·Nicholas J SeversStephen Rothery
May 8, 2010·Basic Research in Cardiology·Shiang Y LimDerek J Hausenloy
Aug 21, 2010·Canadian Journal of Physiology and Pharmacology·Roberta CianfroccaAnna Bagnato
Apr 17, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Satoko IshikawaTetsuji Miura
Jul 21, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Géraldine RathChantal Dessy
Sep 15, 2012·Neuropharmacology·Octavio MoldesJosé Castillo
Mar 1, 2014·Circulation Research·Karin PrzyklenkMaik Hüttemann
Mar 19, 2014·European Journal of Pharmacology·Mai M HelmyMahmoud M Mohy El-Din
Aug 28, 2014·Journal of Translational Medicine·Timo BrandenburgerAndré Heinen
Jan 2, 2015·Molecular and Cellular Biochemistry·Rabia GillRakesh C Kukreja
May 13, 2015·Seminars in Nephrology·Janet J Maguire, Anthony P Davenport
Nov 5, 2015·Naunyn-Schmiedeberg's Archives of Pharmacology·Roohani SharmaAmteshwar Singh Jaggi
Feb 24, 2016·International Journal of Preventive Medicine·Nazgol Esmalian AfyouniMaryam Maleki
Apr 15, 2016·Vascular and Endovascular Surgery·Kate N ThomasAndré M van Rij
May 11, 2016·Clinical and Experimental Pharmacology & Physiology·Mona PourjafarRezvan Najafi
Jul 12, 2017·Circulation Research·Xue ZhaiJonathan H Jaggar
Sep 20, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Na WangEn-Sheng Ji
Jan 27, 2018·Free Radical Biology & Medicine·Susana Cadenas
Feb 18, 2018·Journal of the American Heart Association·Brandon M FoxJennifer S Pollock

❮ Previous
Next ❯

Citations

Jul 1, 2021·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Yuefang LiXin Hu

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.